Defining the standard of care: Randomized controlled trials for the treatment of hepatitis C in the HIV-infected person

被引：5

作者：

Sulkowski, MS ^{[1
]}

机构：

[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA

来源：

HEPATOLOGY | 2004年 / 39卷 / 04期

关键词：

D O I：

10.1002/hep.20191

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：906 / 908

页数：3

共 14 条

[1]

[Anonymous], 1999, MMWR Recomm Rep, V48, P1

[2] National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002 [J].

不详 .

HEPATOLOGY, 2002, 36 (05) :S3-S20

[3] Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon α-2b+ full-course vs 16-week delayed ribavirin [J].

Bräu, N ;

Rodriguez-Torres, M ;

Prokupek, D ;

Bonacini, M ;

Giffen, CA ;

Smith, JJ ;

Frost, KR ;

Kostman, JR .

HEPATOLOGY, 2004, 39 (04) :989-998

[4]

CHUNG R, 2002, 9 C RETR OPP INF FEB

[5] Monitoring of viral levels during therapy of hepatitis C [J].

Davis, GL .

HEPATOLOGY, 2002, 36 (05) :S145-S151

[6] Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa [J].

Dieterich, DT ;

Wasserman, R ;

Bräu, N ;

Hassanein, TI ;

Bini, EJ ;

Bowers, PJ ;

Sulkowski, MS .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (11) :2491-2499

[7] Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: Low eligibility for interferon treatment [J].

Fleming, CA ;

Craven, DE ;

Thornton, D ;

Tumilty, S ;

Nunes, D .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :97-100

[8] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].

Fried, MW ;

Shiffman, ML ;

Reddy, KR ;

Smith, C ;

Marinos, G ;

Goncales, FL ;

Haussinger, D ;

Diago, M ;

Carosi, G ;

Dhumeaux, D ;

Craxi, A ;

Lin, A ;

Hoffman, J ;

Yu, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982

[9] Hospitalization rates differ by hepatitis C status in an urban HIV cohort [J].

Gebo, KA ;

Diener-West, M ;

Moore, RD .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (02) :165-173

[10] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].

Manns, MP ;

McHutchison, JG ;

Gordon, SC ;

Rustgi, VK ;

Shiffman, M ;

Reindollar, R ;

Goodman, ZD ;

Koury, K ;

Ling, MH ;

Albrecht, JK .

LANCET, 2001, 358 (9286) :958-965

← 1 2 →